Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 1516374 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Company search
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Viewing report

Order by Fax
Ask a Question
Printer Friendly
PDF Brochure
Hard CopyAdd to Basket
Live Chat Live Help Software for Website

Dietary Flavonoids and Risk of Breast Cancer and Childhood Leukemia. Edition No. 1

VDM Publishing House, Dec 2010, Pages: 124


  Description  
   Authors   
    
    
    
     
  Enquire before Buying   
  Send to a Friend   

Numerous studies have demonstrated an inverse relationship between dietary flavonoid intake and cancer risk,which may be modified by polymorphisms in flavonoid metabolizing genes such as NQO1.The independent role of dietary flavonoids was explored in breast cancer and childhood leukemia (accounting for NQO1 genotype),using data from the LACE and NCCLS studies,respectively.High daidzein (soy) consumption after a breast cancer diagnosis was associated with a reduced risk of recurrence in postmenopausal women treated with tamoxifen.A significantly reduced risk of childhood leukemia was associated with mothers who consumed the most flavonoids during pregnancy.Carrying the NQO1-2 variant allele was not independently associated with the risk of childhood ALL or AML and there was no significant interaction with flavonoid intake.In a meta-analysis,NQO1-2 had no significant effect on risk of childhood leukemia overall but was associated with an increased risk in a subset of leukemia cases with MLL translocations. These results suggest that high flavonoid intake may be associated with a reduced risk of breast cancer and childhood leukemia.



For enquiries please call us on:
  +353-1-415-1241 (GMT Office Hours)
  1-917-300-0470 (EST Office Hours)

   All rights reserved. © Copyright 2012 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network


Research and Markets RSS Feeds